IPOs and Secondaries
IPOs and Secondaries Articles
More than 3 million PLx Pharma shares are expected to price in the range of $17 to $19 per share in an initial public offering valued up to about $83 million.
Published:
Last Updated:
Neos Therapeutics has filed with the U.S. Securities and Exchange Commission (SEC) regarding its secondary offering.
Published:
Last Updated:
BATS Global Markets has amended its filing with the U.S. Securities and Exchange Commission (SEC) regarding its initial public offering (IPO).
Published:
Last Updated:
To say that the month of January was a bust for initial public offerings (IPOs) is an understatement. January was a complete zero—not a single IPO priced this month making it the first month in...
Published:
Last Updated:
More than 32 million OTG shares are expected to price in the range of $16 to $18 per share in an IPO valued at up to more than $672 million.
Published:
Last Updated:
Tactile Systems Technology has filed with the U.S. Securities and Exchange Commission (SEC) regarding its initial public offering (IPO).
Published:
Last Updated:
Editas Medicine expects to price its nearly 6 million shares in the range of $16 to $18 per share in an initial public offering valued up to more than $122 million.
Published:
Last Updated:
Mapi Pharma expects to price more than 3 million shares in the range of $15 to $17 in an initial public offering valued up to more than $61 million.
Published:
Last Updated:
Albertsons expects to price more than 65 million shares in the range of $23 to $26 in an IPO valued up to nearly $2 billion.
Published:
Last Updated:
The first three weeks of 2016 have not produced a single initial public offering (IPO) but that sad situation may change in the coming week with four offerings on the calendar. With equities selling...
Published:
Last Updated:
Agile Therapeutics fell in Friday’s session, despite the broad markets taking off, after the company announced the pricing for its secondary offering.
Published:
Last Updated:
In a surprise turn of events, Elevate Credit has decided to postpone its initial public offering due to difficult market conditions.
Published:
Last Updated:
ADS Waste Holdings has amended its filing with the U.S. Securities and Exchange Commission (SEC) regarding its initial public offering (IPO).
Published:
Last Updated:
Chances are very high that a lot of opportunists (including the largest oil and gas players) are going to pursue buying assets if they think they are being bought on the cheap.
Published:
Last Updated:
PLx Pharma intends to price its more than 3 million shares in the range of $17 to $19 per share, for an IPO valued up to about $83 million.
Published:
Last Updated: